ArticleOncoimmunology

ATTACK, a novel bispecific T cell-recruiting antibody with trivalent EGFR binding and monovalent CD3 binding for cancer immunotherapy.

Seandean Lykke Harwood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.